BDBM242460 US9422235, 36

SMILES Fc1ccc(Nc2ccc(c(c2)C(F)(F)F)S(=O)(=O)NCC2CC2)c(F)c1

InChI Key InChIKey=SDRWZARPOTZJEG-UHFFFAOYSA-N

Data  7 KI  7 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 7 hits for monomerid = 242460   

TargetCannabinoid receptor 2(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  53nM ΔG°:  -10.1kcal/mole IC50: 106nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  66nM ΔG°:  -9.95kcal/mole IC50: 132nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  68nM ΔG°:  -9.94kcal/mole IC50: 132nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  131nM ΔG°:  -9.54kcal/mole IC50: 215nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 2(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  822nM ΔG°:  -8.43kcal/mole IC50: 1.93E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  3.00E+3nM ΔG°:  -7.66kcal/mole IC50: 6.00E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent

TargetCannabinoid receptor 1(Human)
Pharmos

US Patent
LigandPNGBDBM242460(US9422235, 36)
Affinity DataKi:  3.27E+3nM ΔG°:  -7.60kcal/mole IC50: 5.95E+3nMT: 2°CAssay Description:The binding assays were performed by testing the ability of the new compounds to displace the radiolabeled synthetic non-selective cannabinoid agonis...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/14/2017
Entry Details
US Patent